Company: GEHC
Filing Date: 2025-04-30
Form Type: 10-Q
Source: 0001932393-25-000014
Chunk: 7

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-04-30
Form: 10-Q
Item: Item 8
Chunk 7
---
 joint venture partner Sumitomo Chemical for net cash consideration of $269 million. The acquisition was funded with cash on hand. NMP is a leading pharmaceutical manufacturer in Japan, focused on radiopharmaceuticals, which are used to enable clinical images across neurology, cardiology, and oncology procedures, as well as nonclinical and clinical development of radiotracers and theranostics research. Their product portfolio includes several GE HealthCare radiopharmaceuticals. NMP is included in the Company’s PDx segment.On March 31, 2025, the fair value of the Company’s existing 50% interest in NMP was determined to be $301 million based on the cash consideration exchanged for acquiring the remaining 50% equity interest. The carrying value of our 50% interest was $204 million. The Company recognized a net gain of $97 million resulting from this remeasurement to fair value. This gain included the reclassification of certain amounts related to the Company’s 50% interest out of Accumulated other comprehensive income (loss) – net (“AOCI”) including foreign currency translation gains of $63 million and losses related to a defined benefit pension plan of $8 million. The net gain from this remeasurement was recorded in Other (income) expense – net in the Company’s Condensed Consolidated Statements of Income for the three months ended March 31, 2025.

13

Table of Contents                 

The following table provides a summary of the purchase price consideration transferred for the acquisition of NMP.Purchase considerationCash consideration, net of cash acquired$269 Fair value of previously held interest in NMP301 Fair value of contingent consideration5 Total allocable purchase price$575 The estimated fair values of the assets and liabilities assumed in connection with the acquisition of NMP are as follows.Initial allocationReceivables$53 Inventories10 Property, plant, and equipment243 Goodwill216 Other intangible assets223 All other non-current assets(1)52 Deferred income taxes(87)All other non-current liabilities(107)Other(2)(28)Total net assets post acquisition$575 (1) All other non-current assets includes $12 million of indemnification assets, with the underlying indemnified liabilities recorded in All other non-current liabilities.(2) Other includes Accounts payable, All other current liabilities, and Current compensation and benefits.The initial allocation of purchase price of NMP to the tangible and intangible assets acquired and liabilities